Correlation Between Soleno Therapeutics and Alto Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Alto Neuroscience,, you can compare the effects of market volatilities on Soleno Therapeutics and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Alto Neuroscience,.

Diversification Opportunities for Soleno Therapeutics and Alto Neuroscience,

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Soleno and Alto is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Alto Neuroscience,

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.29 times more return on investment than Alto Neuroscience,. However, Soleno Therapeutics is 3.42 times less risky than Alto Neuroscience,. It trades about 0.08 of its potential returns per unit of risk. Alto Neuroscience, is currently generating about -0.08 per unit of risk. If you would invest  4,895  in Soleno Therapeutics on August 30, 2024 and sell it today you would earn a total of  689.00  from holding Soleno Therapeutics or generate 14.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Soleno Therapeutics  vs.  Alto Neuroscience,

 Performance 
       Timeline  
Soleno Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Alto Neuroscience, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alto Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Soleno Therapeutics and Alto Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Soleno Therapeutics and Alto Neuroscience,

The main advantage of trading using opposite Soleno Therapeutics and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.
The idea behind Soleno Therapeutics and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance